The vaccine has demonstrated a high efficacy rate after one dose, but the company itself has not suggested any policy changes.
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.
Is Pfizer Recommending a Switch to a…
The vaccine has demonstrated a high efficacy rate after one dose, but the company itself has not suggested any policy changes.
Create your profile
Only Dispatch Members only can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.